- Home
- INCR vs IVVD Comparison
INCR vs IVVD Comparison
Compare INCR & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- IVVD
- Stock Information
- Founded
- INCR 1994
- IVVD 2020
- Country
- INCR Israel
- IVVD United States
- Employees
- INCR N/A
- IVVD N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- INCR Health Care
- IVVD Health Care
- Exchange
- INCR Nasdaq
- IVVD Nasdaq
- Market Cap
- INCR 84.5M
- IVVD 69.0M
- IPO Year
- INCR N/A
- IVVD 2021
- Fundamental
- Price
- INCR $1.55
- IVVD $0.74
- Analyst Decision
- INCR
- IVVD Strong Buy
- Analyst Count
- INCR 0
- IVVD 3
- Target Price
- INCR N/A
- IVVD $5.85
- AVG Volume (30 Days)
- INCR 24.5K
- IVVD 1.3M
- Earning Date
- INCR 08-15-2025
- IVVD 08-13-2025
- Dividend Yield
- INCR N/A
- IVVD N/A
- EPS Growth
- INCR N/A
- IVVD N/A
- EPS
- INCR N/A
- IVVD N/A
- Revenue
- INCR $65,575,323.00
- IVVD $36,688,000.00
- Revenue This Year
- INCR $69.54
- IVVD $446.60
- Revenue Next Year
- INCR $41.75
- IVVD $112.63
- P/E Ratio
- INCR N/A
- IVVD N/A
- Revenue Growth
- INCR N/A
- IVVD N/A
- 52 Week Low
- INCR $1.17
- IVVD $0.35
- 52 Week High
- INCR $2.62
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- INCR 60.11
- IVVD 48.03
- Support Level
- INCR $1.48
- IVVD $0.70
- Resistance Level
- INCR $1.56
- IVVD $0.77
- Average True Range (ATR)
- INCR 0.06
- IVVD 0.05
- MACD
- INCR 0.01
- IVVD -0.00
- Stochastic Oscillator
- INCR 80.99
- IVVD 45.94
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.